Cargando…
Barriers and facilitators to chemotherapy initiation and adherence for patients with HIV-associated Kaposi’s sarcoma in Kenya: a qualitative study
BACKGROUND: Kaposi sarcoma is one of the most prevalent HIV-associated malignancies in sub-Saharan Africa and is often diagnosed at advanced stage of disease. Only 50% of KS patients who qualify for chemotherapy receive it and adherence is sub-optimal. METHODS: 57 patients > 18 years with newly d...
Autores principales: | McMahon, Devon E., Singh, Rhea, Chemtai, Linda, Semeere, Aggrey, Byakwaga, Helen, Grant, Merridy, Laker-Oketta, Miriam, Lagat, Celestine, Collier, Sigrid, Maurer, Toby, Martin, Jeffrey, Bassett, Ingrid V., Butler, Lisa, Kiprono, Samson, Busakhala, Naftali, Freeman, Esther E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258164/ https://www.ncbi.nlm.nih.gov/pubmed/35794634 http://dx.doi.org/10.1186/s13027-022-00444-0 |
Ejemplares similares
-
Telling the story of intersectional stigma in HIV‐associated Kaposi's sarcoma in western Kenya: a convergent mixed‐methods approach
por: Collier, Sigrid, et al.
Publicado: (2022) -
A type III effectiveness-implementation hybrid evaluation of a multicomponent patient navigation strategy for advanced-stage Kaposi’s sarcoma: protocol
por: Collier, Sigrid, et al.
Publicado: (2022) -
Real-world use of chemotherapy for Kaposi’s sarcoma in a large community-based HIV primary care system in Kenya
por: Freeman, Esther E., et al.
Publicado: (2020) -
A prospective ascertainment of cancer incidence in sub‐Saharan Africa: The case of Kaposi sarcoma
por: Semeere, Aggrey, et al.
Publicado: (2016) -
Accuracy of Clinical Suspicion and Pathologic Diagnosis of Kaposi Sarcoma in East Africa
por: Amerson, Erin, et al.
Publicado: (2016)